OP5-005 Using Omnipod 5 in Adults With Type 2

NACompletedINTERVENTIONAL
Enrollment

343

Participants

Timeline

Start Date

April 11, 2023

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2024

Conditions
Type2 Diabetes
Interventions
DEVICE

Omnipod 5 Automated Glucose Control System

The Omnipod Horizon™ Automated Glucose Control System will provide automated insulin delivery

Trial Locations (21)

10461

Albert Einstein College of Medicine, The Bronx

27514

University of North Carolina, Chapel Hill

27834

Physicians East, Greenville

28401

AccellaCare, Wilmington

28803

MAHEC, Asheville

30076

Endocrine Research, Roswell

30114

East Coast Institute for Research, Canton

30303

Emory, Atlanta

32216

East Coast Institute for Research, Jacksonville

33401

Metabolic Research Institute, West Palm Beach

37411

University Diabetes and Endocrine Consultants, Chattanooga

43203

Ohio State, Columbus

48202

Henry Ford, Detroit

55416

Health Partners, Minneapolis

76132

Diabetes and Thyroid Center, Fort Worth

78229

Diabetes and Glandular Disease Clinic, San Antonio

78731

Texas Diabetes and Endocrinology, Austin

80045

University of Colorado, Aurora

90022

University of Southern California, Los Angeles

93105

Sansum Diabetes Research Institute, Santa Barbara

02215

Joslin Diabetes, Boston

Sponsors
All Listed Sponsors
collaborator

Jaeb Center for Health Research

OTHER

lead

Insulet Corporation

INDUSTRY